IOT Innovotech Inc

Innovotech (TSX VENTURE:IOT) - Media are invited to a press conference
announcing a clinically-proven test of immense interest to the medical community
and people everywhere dealing with chronic infections that are potentially life
threatening.


The benefits of this test include reducing the incidents of resistance to
antibiotics and savings to the health care system. It has received regulatory
approval by Health Canada and has met all current standards of the Clinical
Laboratory Standards Institute (CLSI) for reproducibility and consistency.


Press conference details:

When: Tuesday, July 28, 2009 - 10 a.m.

Where: 203 Advanced Technology Centre in Edmonton Research Park, 9650 20 Avenue NW

Available for interviews will be the two doctors who led the clinical research
as well as one of the patients in the study and the CEO of Innovotech. A tour of
the lab where the test was developed will be conducted following the press
conference. A DVD of stock footage and interview clips is available upon
request.


Toronto-based media please note that a further clinical evaluation of this test
is now underway at the Hospital for Sick Children and St. Michael's Hospital.
The doctor leading the evaluation at St.Michael's Hospital is also available for
interviews.

Innovotech (TSXV:IOT)
Historical Stock Chart
From Jun 2024 to Jul 2024

Innovotech (TSXV:IOT)
Historical Stock Chart
From Jul 2023 to Jul 2024